CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup

Kristine Aasebø(University of Bergen), Halfdan Sørbye(Haukeland University Hospital)
Frontiers in Oncology
February 11, 2020
Cited by 66


Related Papers

No related papers found

Powered by citation graph analysis